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PaocEDtrm~
Thirty unselected mongrel dogs ranging in weight from 6.7 to 26.0 kg. ( average 13.0 kg.) were studied. Without premedication I each dog was anaesthetized intravenously with 15-20 mg./kg, of methohexital sodium; the trachea was intubated with a cuffed orotracheal tube. The animal then was placed in the right lateral recumbent position and the endotracheal tube was connected to a precision volume respirator which delivered 100 per ce~)t oxygen at 22 cycles per minute. The tidal volume was adjusted so that the end-expiratory CO2 was maintained at 5.6 per cent throughout the procedure. A polyethylene catheter was inserted through the femoral artery into the abdominM aorta and was attached to a pressure transducer. Through a thoracotomy in the left fifth interspace, a s~rain gauge arch was sutured to the left ventricle, according to the method of Boniface et al. s The connecting wires were led outside the chest, the lung was inflated, and the thoracotomy was closed. ECG and EEG needle electrodes were app~lie~]. Then the dog was allowed to recover until he began to struggle and until the EEG revealed low-voltage least activity. At this point, recordings of cardiac contractile force, aortic blood pressure, electrocardiogram, and electroencephalogram were made; these data served as controls for the remainder of the experiments.
Methoxyflurane was then introduced into the bre~ithing system in 0.5 per cent 
METHODS
Artificial respiration was provided by a Harvard Respirator via a non-rebreathing system. End-expiratory carbon d/oxJde was measured by / a Beckman LB1 Medical gas analyser with a breathe-through cell. The output signa! was }ecorded continuously by a Texas Instruments t{ee~ilinear recorder. Aorhc blood pressure was measured with a Statham strain gauge, model P23D. Myogardial contractile force was measured by a 120-ohm Walton-Brodie strain gaug~ arch. Limb lead II electrocardiographic recordings were made continuously laccording to the method of LarmekP Eleetroencephalographic recordings wei'e obtained from bipolar needle electrodes 5 cm. apart in a left fronto-occipital position with a ground electrode over the righFparletal area. A calibration of 100 mlcrovolt ---2.0 era. deflection was employed. TI~e latter four signals were l~d to appropriate preamplifiers and recorded by a Sanborn Model 150 multicharmel recorder.
A special vaporization system was designed to deliver accurate, reproducible concentrations of methoxyflurane ( (Table I) to provide the appropriate concentrations of methoxyflurane. 
RESULTS
Where appropriate, the changes observed ir~ the thirty dogs are averaged and the results are expressed as the percentage of the control values. (Fig. 2) . In Run A the contractile force decreased as the concentration of methoxyflurane increased, falling to 52 per cent of the control value after exposure to the 2 per cent I mixttLre. Upon decremental withdrawal of the agent, a lag in the recovery of !myocardial contractility occurred. / / withdrawal of methoxyflurane), the myoeardial cont~aetilel force remained depressed 15 per cent. During 'Run B, even though the contractile force was partiallk depressed' at the beginning, ,~e same increases in concentration did not d~press~ eonfa-actility to a greater extent than had occurred in Run A but the depre~ssion, plateau remained for a longer period of time.
Myocardial contractile force
Systolic blood pressure (Fig. 3) . The systolic blood pressure followed essen-I
J '
tially the same pattern of depression and recovery; the per cent changes were almost identical with those which occurred in the contractile force. Diastolic blood pressure (Fig. 4) . The diastolic blood pressuredecreased to 45 per cent of the initial level in response to 2 per cent methoxyflurane and recovery was delayed slightly longer~t the end of both runs the diastolic pressure had not ~-eturned to its original value. Pulse pressure (Fig. 5) . The pulse pressure decreased moderately during Run A (65 per cent of control value at maximum concentration) and further depression occurred during Run B.
Heart rate and rhythm (Fig. 6) . The heart rate decreased progressively as the concentration of the agent increased. At the end of Run A, the rate was 80 per cent of the control value. During Run B there was a very slight trend towards a further decrease in heart rate. Electroencephalogram. As depth of anaesthesia increased, low-voltage fast activity changed to slower (10-15 e.p:s.)wayes wtth higher voltage. Spindle forms did not appear. In deeper stages superimposed fast activity disappeared. The greatest amount of cerebral depression pro~uce~ slow (1-2 c.p.s.), high-voltage (50-100 mierovolt) wave forms, sometimes/interrupted by burst suppression lasting up to 5 seconds. Figure 7 shows tracings typical of most ~ecords obtained serially at the end of each 15-minute exposure period during Ru / A. Occasional deviations 'from these patterns occurred, and in a few instances this aplJeared to be relzted to the size of the animal. The EEG exhibited a delay in recovery similar to that wl~ich efiaracterized changes in contractile force and blood pressure. This was most evident during withdrawal of the drug. Exposure tO 2 p~r cent methoxyflurane produced burst suppression in 35 per cent of the tracings; at the end of the next 15-minute period, when the dogs were inhaling only 1.5 p~r cent vapour, burst suppression was present in 45 per cent of the records. ]Burst shppression was closely related to the severity of hypotension. When the blood pressure remained above 90 ram. Hg, burst suppression did not develop. When suppression was observed, the average systolic pressure was 66 mm. Hg.
DISCUSSION
The control values employed in these experiments doubtless are influenced by a number of factors, prominent among which are the residual effects of methohexital and the effects produced when the animal~were allowed to awaken to the point of reacting to the stimulation of the endotracheal tube and other appliances. It would seem reasonable to expect, however, ~at these two conditions would tend to offset one another; thus the control data, while in no way reflecting a steady state, provide practical points of reference for the subsequent measurements.
The duration of exposure .to eaeh incremental and decremental concentration was chosen somewhat arbitrarily, with the full realization that true equilibration did not occur. Initially, " " .... ' " l~ad a 7-minute exposure penod was tried, since this proved satisfactory for similar experiments with hMothane. However, it Was readily apparent that haemodynamic responses did not stabilize during this inferval; therefore the exposure time was doubled. The 1"5-minute period furnished satisfactory stabilization of cardiovaseular function (Fig. 8) .
A definite lag occurred in the recovery of all ~tmctionslmonitored during w~th-drawal of the agent. Thomason et al. 1~ have pointed out that methoxyflurane has a high water and oil solubility and that the body's capacity to sto~ it is high. 1"2 noted that obese patients a.wak~ned more rapidly following prolonged methoxyflurane administration than did lean Ipatients. He concluded that the blood concentration fell more rapidly v~laen the agent could escape into abundant fatty deposits while at the same time it w;Ls being exhaled. The lean patient on the other hand must depend solely upon p ulmo1~ary exchange to reduce the blood concentration. The animals studied her( wer~ obtained direcdy from the supplier one or two days ~prior to the experimer t; they tended to be malnourished and underweight. It seems likely that the slow reeoyery of haemodynamie functions observed in these lean animals is a refleetionlof the gradual reduction of blood and tissue stores primarily through alveolar excretion, with little or no reapportionment to fatty depots.
The myocardial contractile force measurements xleported here are in general agreement with those of Bagwel] et al. 11 although our figures reveal somewhat less depression of contractility at the low cone9ntrations of methoxyiturane. This disparity is understandable since the above worker's 'induced anaesthesia with 3 per cent methoxyflurane and then reduced the in~aaled concentration to lower levels for purposes of cardiovascular evaluation. In ~e light of the emergence lag described above, it is likely that tissue levels at each inhaled concentration were significantly higher in their animals than in ours.
Systolic and diastolic blood pressure and pulse pressure exhibited responses which paralleled myocardial contractility.' These ellanges ar~ indicative of the general cardiovascular depressant properties of thi~ agent. Most noteworthy is the almost identical per cent changes observed fo, systolic pressure and myocardial contractility ( Fig. 9) .
Rigid eonffol of ventilation prevented the data tr being influenced by the effects of respiratory acidosis which occurs with s~ontaneous inhalation of this agent. 5 But our efforts to maintain tl3e end expiratory, concentration of carbon dioxide at 5.6 per cent may have introduced effects traceable to the intermittent positive-pressure respiration. W~ant: et al. TM showed that wit~ methoxyflurane anaesthesia the total peripheral resistance decreased duripg spqntaneous respirat-ion and increased slightly above the initial value during controlled respiration. Since the poise pressure showed ao moderate decrease in ou't~" experiments, an increase in peripheral resistance may have a,ccompaoiedl the artificial breathing during methoxyflurane anaesthesia. Bagwells demonstration that sympathetic reflexes are still reactive during methoxyflurane anaesthesia 11 suggests that an autonomic response to pulmonary inflation is indeed possible in/this circumstance.
The experience of some workers 11,~ indicates that no sig-nificalat ch~mge in pulse rate accompanies methoxyflurane administration. Our d.ata shgw that in dogs a moderate sinus bradycardia occurs frequently and persists despite withdrawal of the agent. P-wave and PR-interval changes suggest that this bradycardia may be the result of vagal predominance. Abnormal rhythm was an~nfrequent occurrence in this study; this is in agreement with other studies in dogs and man.2,11 12,1~
The T-wave alterations constituted one of the most constant~and striking findrags of the study. This has not been described previously. It is interesting to note that the T-wave changes occurred even during the administration of low concentrations of methoxyflurane and at a time when myocardial contl'actility and blood pressure were minimally depressed. We have no explanatioD for this finding, which suggests that some change in the repolarization occurred I
The unusual amount of EEG burst suppression is an interqsting finding. It is absent in most previous studies in man ~,s,~4 probably becausethe blood pressure of the subjects was not allowed to reach such hypotensive levels. However, Knox st al. ~5 published a grap11~aken from one human subject wifich showed burst suppression despite a normal, blood pressure. We/eel that .~.e appearance and duration of burst suppression in this series col:relates well with reduced systolic blood pressure, pulse pressure, and contractile force.
SU~IV~ARY
Methoxyflurane was administered to unpremedicated dogs in increasing and decreasing concentrations while normal pulmonary ventilation was rigidly mainrained. Myocardial contractAity, blood pressure, pulse rate, electrocardiogram, and electroencephalogram were recorded continuously.
A progressive decrease in contractile force of the heart muscle resulted as the inhaled concentration of methoxyflurane increased. A parallel decrease _in systolic, diastolic, and pulse pressure occurred. Sinus bradycardia and an alteration in repolarization of cardiac muscle accompanied the dynamic changes. A lag occurred in recovery of all cardiovascular functions and the EEG following withdrawal of the agent. Burst suppression appeared when hypotension below 90 ram. Hg occurred.
A comparison bf the results of this study with those previously reported is presented.
